Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Transpl Infect Dis. 2019 Jul 31;21(5):e13145. doi: 10.1111/tid.13145

Table 2:

Immunopathology of 167 PTLD cases in which pathology reports available

Variable EBV positive [N(%)] EBV negative [N(%)] p-value
Number of patients 135 32
Morphologic Type 0.188
 Monomorphic 88 (65) 21 (66)
 Polymorphic 38 (28) 6 (19)
 Missing 9 ( 7) 5 (16)
Ki67 staining 0.367
 40–69 8 ( 6) 2 ( 6)
 70–79 8 ( 6) 0
 80–89 12 ( 9) 1 ( 3)
 ≥90 18 (13) 7 (22)
 Missing 89 (66) 22 (69)
Bcl6 staining 0.438
 Positive 14 (10) 4 (13)
 Negative 17 (13) 1 ( 3)
 Not tested/Not reported 104 (76) 27 (84)
Bcl2 staining 0.655
 Positive 27 (20) 9 (28)
 Negative 2 ( 1) 0
 Not tested/Not reported 106 (78) 23 (72)
CD20 staining 0.120
 Positive 100 (74) 19 (59)
 Negative 3 ( 2) 0
 Not tested/Not reported 32 (24) 13 (41)
CD30 staining 0.469
 Positive 34 (25) 9 (28)
 Negative 5 ( 4) 0
 Not tested/Not reported 96 (71) 23 (72)
Pathology 0.636
 PTLD 91 (67) 19 (59)
 DLBCL 39 (29) 12 (38)
 Others 5 ( 4) 1 ( 3)
Subtype 0.963
 DLBCL 58 (43) 15 (47)
 Polymorphic PTLD 27 (20) 6 (19)
 Burkitt 2 ( 1) 1 ( 3)
 PTLD NOS 24 (18) 5 (16)
 Plasmacytoid 13 (10) 3 ( 9)
 T-cell NOS 2 ( 1) 1 ( 3)
 Monomorphic PTLD 2 ( 1) 0
 No morphology 4 ( 3) 0
 Missing 3 ( 2) 1 ( 3)